Profiles for companies starting with 'm'
✉ Email this page to a colleague
Drugs and US Patents for m
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Labs Ltd | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | POWDER;INTRAVENOUS | 209481-004 | Jul 10, 2018 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan | MYCOPHENOLATE MOFETIL | mycophenolate mofetil | TABLET;ORAL | 065521-001 | May 4, 2009 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mankind Pharma | BUMETANIDE | bumetanide | TABLET;ORAL | 219291-003 | Apr 3, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Msn | MIRABEGRON | mirabegron | TABLET, EXTENDED RELEASE;ORAL | 218543-001 | Nov 4, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
